Oral Dosage Form New Animal Drugs: Ivermectin, Fenbendazole, and Praziquantel Tablets
FR, June 13, 2008 › Rules › Food and Drug Administration
Linked as:FR, June 13, 2008 › Rules › Food and Drug Administration
Linked as:Text
Federal Register: June 13, 2008 (Volume 73, Number 115)
Rules and Regulations
Page 33692
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
DOCID:fr13jn08-12
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration 21 CFR Part 520
Oral Dosage Form New Animal Drugs; Ivermectin, Fenbendazole, and
Praziquantel Tablets
AGENCY: Food and Drug Administration, HHS.
ACTION: Final rule.
SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of an original new animal drug application (NADA) filed by Intervet, Inc. The NADA provides for the veterinary prescription use of chewable tablets containing ivermectin, fenbendazole, and praziquantel for the treatment and control of various internal parasites and for the prevention of canine heartworm disease in adult dogs.
DATES: This rule is effective June 13, 2008.
FOR FURTHER INFORMATION CONTACT: Melanie R. Berson, Center for
Veterinary Medicine (HFV-110), Food and Drug Administration, 7500
Standish Pl., Rockville, MD 20855, 240-276-8337, e-mail: melanie.berson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: Intervet, Inc., P.O. Box 318, 29160 Intervet
Lane, Millsboro, DE 19966, filed NADA 141-286 that provides for the veterinary prescription use of PANACUR Plus (ivermectin, fenbendazole, and praziquantel) Soft Chews for the treatment and control of various internal parasites and for the prevention of canine heartworm disease in adult dogs. The NADA is approved as of May 9, 2008, and the regulations are amended in 21 CFR part 520 by adding Sec. 520.1200 to reflect the approval.
In accordance with the freedom of information provisions of 21 CFR part 20 and 21 CFR 514.11(e)(2)(ii), a summary of safety and effectiveness data and information submitted to support approval of this application may be seen in the Division of Dockets Management
(HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852, between 9 a.m. and 4 p.m., Monday through Friday.
Under section 512(c)(2)(F)(ii) of the Federal Food, Drug, and
Cosmetic Act (21 U.S.C. 360b(c)(2)(F)(ii)), this approval qualifies for 3 years of marketing exclusivity beginning on the date of approval.
The agency has determined under 21 CFR 25.33(d)(1) that this action is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required.
This rule does not meet the definition of ``rule'' in 5 U.S.C. 804(3)(A) because it is a rule of ``particular applicability.''
Therefore, it is not subject to the congressional review requirements in 5 U.S.C. 801-808.
List of Subjects in 21 CFR Part 520
Animal drugs. 0
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is amended as follows:
PART 520--ORAL DOSAGE FORM NEW ANIMAL DRUGS 0 1. The authority citation for 21 CFR part 520 continues to read as follows:
Authority: 21 U.S.C. 360b. 0 2. Add Sec. 520.1200 to read as follows:
Sec. 520.1200 Ivermectin, fenbendazole, and praziquantel tablets.
(a) Specifications. Each chewable tablet contains either:
(1) 68 micrograms ([micro]g) ivermectin, 1.134 grams fenbendazole, and 57 milligrams (mg) praziquantel; or
(2) 27 [micro]g ivermectin, 454 mg fenbendazole, and 23 mg praziquantel.
(b) Sponsor. See No. 057926 in Sec. 510.600(c) of this chapter.
(c) Conditions of use in dogs--(1) Amount. Administer tablets to provide 6 [micro]g per kilogram (/kg) ivermectin, 100 mg/kg fenbendazole, and 5 mg/kg praziquantel.
(2) Indications for use. For the treatment and control of adult
Toxocara canis (roundworm), Ancylostoma caninum (hookworm), Trichuris vulpis (whipworm), and Dipylidium caninum (tapeworm), and for the prevention of heartworm disease caused by Dirofilaria immitis in adult dogs.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Dated: June 4, 2008.
Bernadette Dunham,
Director, Center for Veterinary Medicine.
FR Doc. E8-13354 Filed 6-12-08; 8:45 am
BILLING CODE 4160-01-S
Sponsored links
ver las páginas en versión mobile | web
ver las páginas en versión mobile | web
© Copyright 2012, vLex. All Rights Reserved.
Contents in vLex United States
Explore vLex
For Professionals
For Partners
Company
Other documents:
gaylord nelson, at 89; 'the father of earth day' ; championed conservation as wisconsin governor, senator | Nursing Homes Among Top Hazardous Workplaces ; No. 3 On Labor List, but Not Governed by Osha Rules | Science: All About Animals | The Holy Pretence; a Study in Christianity and Reason of State From William Perkins to John Winthrop. (Reprint, 1957) | decisión nº 1e777-07 de juzgado primero de primera instancia en lo penal en funciones de ejecución del l.o.p.n.a de apure extensión san fernando de apu... | Decisión de Tribunal Sexto de Primera Instancia de Juicio del Trabajo de Caracas, de May 13, 2011 | Decisión nº PJ0022010000093 de Tribunal Segundo de Primera Instancia de Sustanciación, Med... | Decisión de Juzgado Segundo Superior Del Trabajo de Caracas de April 24 2009